Pricing Log in Create free account

Allogene Therapeutics, Inc. (ALLO) vs BlossomHill Therapeutics, Inc. (BLSM)

Allogene Therapeutics, Inc. and BlossomHill Therapeutics, Inc. are both Biotechnology companies. Allogene Therapeutics, Inc. and BlossomHill Therapeutics, Inc. are of similar size ($392.6M and $376.6M). BlossomHill Therapeutics, Inc. has the higher net margin (0.00% vs −3,517.4%) and the higher return on invested capital (0.00% vs −108.8%). Across the 11 metrics below, BlossomHill Therapeutics, Inc. leads on 6 and Allogene Therapeutics, Inc. on 5.

Valuation

Metric ALLO BLSM Biotechnology median
P/E n/m n/m 10.60
P/S 72.71 n/m 9.40
P/B 0.78 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.82 0.66
EV/Sales 2.02 n/m 9.02
Earnings yield (64.42%) (200.83%) (32.88%)
Free cash flow yield (29.99%) (180.38%) (23.13%)

Profitability

Metric ALLO BLSM Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (3,832.45%) 0.00% 0.00%
Net margin (3,517.41%) 0.00% 0.00%
Free cash flow margin (2,180.62%) 0.00% 0.00%
Return on equity (42.39%) 0.00% (51.96%)
Return on assets (32.43%) 0.00% (46.06%)
Return on invested capital (108.81%) 0.00% 0.00%

Growth

Metric ALLO BLSM Biotechnology median
Revenue growth (TTM) 7,613.11% — 6.76%
EPS growth (last fiscal year) 34.09% (85.30%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ALLO BLSM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.72 5.42 4.97
Net debt to EBITDA 1.24 2.15 1.01

Dividend

Metric ALLO BLSM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ALLO BLSM Biotechnology median
Market cap 376.58m 392.55m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack